Lesson 1High-intensity statin initiation: timing, expected benefits, monitoring for adverse effectsExplains when and how to begin high-strength statins in suspected ACS, anticipated plaque stabilisation gains, starting labs, watching for muscle or liver harm, and advice for long-term sticking to it.
Timing of statin start in ACS pathPicking right statin and doseStarting liver and muscle checksWatching for muscle harm and liver toxicityPatient advice and sticking supportLesson 2Oxygen therapy: evidence-based thresholds for use, titration to target SpO2, risks of hyperoxiaLooks at oxygen therapy in suspected ACS, stressing proof-based start limits, adjusting to target oxygen levels, avoiding too much oxygen, and noting reasons and patient response.
When to start oxygen in suspected ACSTarget SpO2 ranges and adjustment stepsRisks and ways too much oxygen harmsDevice choice and flow changesWatching and noting oxygen responseLesson 3Nitroglycerin: sublingual administration steps, hemodynamic checks, contraindications (PDE-5 inhibitors), management of hypotensionOutlines safe nitroglycerin use, including under-tongue steps, before and after dose blood flow checks, no-go factors like PDE-5 drugs, and handling low blood pressure from nitro.
Under-tongue nitroglycerin stepsPre-dose blood pressure and pain checksChecking for PDE-5 drug useSpotting nitroglycerin side effectsHandling and noting low blood pressureLesson 4Aspirin: dosing, mechanism in ACS, contraindications, assessment before and after administrationGives a targeted review of aspirin in ACS, including starting and ongoing doses, blood clot prevention way, no-go factors, and planned checks before and after giving for safety and effect.
Aspirin starting and ongoing dosingWay of stopping blood clots in ACSNo-go factors and cautionsPre-dose check and risk screeningAfter-dose watching and recheckLesson 5Medication interaction and allergy checks: cross-checking home meds, diabetes and beta-blocker interactions, renal dosing considerationsFocuses on methodically spotting allergies, past bad reactions, and high-risk drug mixes, including diabetes treatments, beta-blockers, and kidney-cleared drugs, to stop avoidable harm in ACS patients.
Organised allergy and reaction historyCross-checking home and hospital drugsDiabetes drugs and beta-blocker hidingKidney dosing and harmful combosUsing system alerts and pharmacist helpLesson 6Overview of ACS pharmacotherapy: antiplatelets, anticoagulants, nitrates, beta-blockers, statins, oxygen rationaleReviews main ACS drugs, their ways, needs, and no-go factors, stressing first choice, order, and bedside safety checks to balance blood flow relief with bleeding and blood pressure risks.
Roles of anti-clot agents in ACSAnticoagulant choices and pickingUse of nitrates for lack-of-blood chest painEarly beta-blocker therapy thoughtsHigh-strength statins in ACS careOxygen use and current ACS proofLesson 7Anticoagulation with enoxaparin: dosing based on weight/renal function, timing relative to procedures, bleeding risk assessment and monitoringCovers enoxaparin for ACS blood thinning, including weight and kidney-based dosing, timing around invasive steps, bleeding risk check, watching plans, and working with heart team.
Weight-based dosing calculationsKidney issue dose changesTiming with PCI and other stepsStarting and ongoing bleeding checkWatching anti-Xa and lab measuresReversing and handling major bleedingLesson 8Beta-blockers (metoprolol): indications, IV vs PO use, blood pressure and heart rate criteria, dose titration and monitoring for bradycardiaReviews metoprolol in ACS, including needs, picking IV versus oral, blood pressure and heart rate limits, adjustment plans, and watching for slow heart rate, low pressure, and breathing issues.
Needs and no-go in ACSIV versus oral metoprolol pickBlood pressure and heart rate limitsDose adjustment and recheckWatching for slow heart and low pressureLesson 9Documentation and communication with the provider about medication responses and lab-guided adjustmentsDetails top ways for noting drug reasons, responses, and bad events, and updating providers to guide lab-based dose changes and therapy step-up or step-down.
Recording reasons and dosing timeNoting responses and side effectsSharing critical changes quicklyUsing labs to guide dose changesHandoff reports and team notesLesson 10Monitoring for adverse effects: hypotension, bradycardia, bleeding, allergic reactions, and stepwise response algorithmsCovers early spotting and handling of low pressure, slow heart, bleeding, and allergy reactions after ACS drugs, using step-by-step plans, escalation signs, and noting response to actions.
Vital sign and blood flow watchingBleeding risk signs and bedside checksSpotting drug-caused slow heartIdentifying and treating allergy reactionsStep-by-step response and escalation pathsAfter-event recheck and noting
